6°C

overcast clouds

TFL Updates
London Daily News

Mayor allocates £22m to London health and quantum projects

Mayor allocates £22m to London health and quantum projects

Three London projects working on health and quantum technology have been selected for a total of £22 million in innovation funding, the Mayor of London announced on 15 November.

Two health-focused partnerships will receive £5 million each. A further £12 million will support the London Quantum Cluster, which brings universities and businesses together across central and west London.

The money comes from the capital’s £30 million allocation under the Local Innovation Partnerships Fund, a national programme intended to help research move towards commercial use. The remainder of London’s allocation is to be assigned in due course.

The announcement identifies more than £98 million in additional match funding across the three projects. That figure includes pledged contributions, so it should not be taken to mean that all the money has already been paid. Together with the £22 million allocation, the identified investment exceeds £120 million.

Research and new health technologies

One of the £5 million awards is for a venture builder led jointly by the BioInnovation Institute and King’s College London. It aims to turn research into cardiometabolic conditions into viable businesses developing treatments and medical technologies.

The field includes conditions such as diabetes, obesity and heart disease. The partnership is intended to help promising research progress towards practical use, including approaches that could detect heart disease earlier or prevent serious complications.

Those are aims for the work, rather than evidence that new treatments have already been approved or made available to patients. Developing an idea into a usable treatment or medical technology can involve further testing and evaluation.

A second £5 million will support PHIX London, led by UCLPartners. The project will work with NHS and private healthcare providers in the Harley Street Health District to help businesses test and scale health technologies.

Its proposed areas of work include ways to detect and monitor high blood pressure and irregular heart rhythms. The intention is to help technologies that perform well in testing move towards wider use, rather than assume that every product tested will be adopted.

The two projects address different stages of innovation. The venture builder is focused on turning research into businesses, while PHIX is intended to help companies assess and expand the use of health technologies with healthcare providers.

Backing an existing quantum cluster

The largest individual allocation, £12 million, will go towards strengthening the London Quantum Cluster. University College London, Imperial College London and King’s College London founded the cluster, which already connects researchers with businesses and investors.

The work spans the Knowledge Quarter around King’s Cross, Bloomsbury and Euston, as well as the WestTech London innovation ecosystem in the west of the capital. The funding is intended to help growing companies test technologies, seek investment and explore applications in fields including healthcare, transport, finance and energy.

Quantum technologies include computing, sensing and communications. Potential uses cited for the London work range from developing medicines to improving transport and energy networks. These are possible applications, not evidence that the projects have already delivered them.

The cluster itself is not new. It was launched in 2025 with earlier mayoral seed funding, with the aim of connecting university research to the resources and commercial support that young companies need. The new allocation is intended to build on that existing collaboration.

How the funding was selected

The London awards form part of a wider national programme worth up to £500 million. It is designed to bring researchers, businesses and civic partners together around local strengths and support innovation that is closer to reaching the market.

London’s Frontier Innovation Board set the funding priorities. The projects were selected after an open call and were also assessed by an independent expert panel. The grants will be managed by City Hall and UK Research and Innovation.

The announcement coincides with London Life Sciences Week, which runs from 15 to 20 November and brings together researchers, businesses and investors for events across the capital. For the selected partnerships, the funding marks a step in developing their plans; the announcement does not establish that every contribution has been paid or that the intended benefits have already been achieved.

Pin It on Pinterest